Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy L Rhine

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cell|October 13, 2015
Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase IIKathleen A Burke, Abigail M Janke, Christy L Rhine, et al.
Nature Communications|June 7, 2020
Mutational bias and the protein code shape the evolution of splicing enhancersStephen Rong, Luke Buerer, Christy L Rhine, et al.
Human Genetics|August 7, 2017
Defective splicing of the RB1 transcript is the dominant cause of retinoblastomasKamil J Cygan, Rachel Soemedi, Christy L Rhine, et al.
Plos Genetics|March 6, 2018
Hereditary cancer genes are highly susceptible to splicing mutationsChristy L Rhine, Kamil J Cygan, Rachel Soemedi, et al.
Human Mutation|July 13, 2019
Future directions for high-throughput splicing assays in precision medicineChristy L Rhine, Christopher Neil, David T Glidden, et al.
Nature Genetics|April 19, 2017
Pathogenic variants that alter protein code often disrupt splicingRachel Soemedi, Kamil J Cygan, Christy L Rhine, et al.
Methods (San Diego, Calif.)|June 10, 2017
The effects of structure on pre-mRNA processing and stabilityRachel Soemedi, Kamil J Cygan, Christy L Rhine, et al.
Plos Genetics|January 20, 2022
Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genesChristy L Rhine, Christopher Neil, Jing Wang, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illnessSean F Monaghan, Debasree Banerjee, Chun-Shiang Chung, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cell|October 13, 2015
Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase IIKathleen A Burke, Abigail M Janke, Christy L Rhine, et al.
Nature Communications|June 7, 2020
Mutational bias and the protein code shape the evolution of splicing enhancersStephen Rong, Luke Buerer, Christy L Rhine, et al.
Human Genetics|August 7, 2017
Defective splicing of the RB1 transcript is the dominant cause of retinoblastomasKamil J Cygan, Rachel Soemedi, Christy L Rhine, et al.
Plos Genetics|March 6, 2018
Hereditary cancer genes are highly susceptible to splicing mutationsChristy L Rhine, Kamil J Cygan, Rachel Soemedi, et al.
Human Mutation|July 13, 2019
Future directions for high-throughput splicing assays in precision medicineChristy L Rhine, Christopher Neil, David T Glidden, et al.
Nature Genetics|April 19, 2017
Pathogenic variants that alter protein code often disrupt splicingRachel Soemedi, Kamil J Cygan, Christy L Rhine, et al.
Methods (San Diego, Calif.)|June 10, 2017
The effects of structure on pre-mRNA processing and stabilityRachel Soemedi, Kamil J Cygan, Christy L Rhine, et al.
Plos Genetics|January 20, 2022
Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genesChristy L Rhine, Christopher Neil, Jing Wang, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illnessSean F Monaghan, Debasree Banerjee, Chun-Shiang Chung, et al.
Pageof 1